Publications Database

Aman M. G. (2004)

Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder.

Seminars in Pediatric Neurology

11(3), pp. 225-228

Read Abstract (New Window)

Aman M. G. , Hollway J. A. , Arnold L. E. (2008)

Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 713-738

Read Abstract (New Window)

Dowben J. , Grant J. , Keltner N. (2011)

Clonidine: diverse use in pharmacologic management.

Perspectives in Psychiatric Care

47(2), pp. 105-108.

Read Abstract (New Window)

Fankhauser M. et al. (1992)

A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism.

Journal of Clinical Psychiatry

53(3), pp. 77-82

Read Abstract (New Window)

King B. H. (2000)

Pharmacological treatment of mood disturbances, aggression and self-injury in persons with pervasive developmental disorders.

Journal of Autism and Developmental Disorders

30(5), pp. 439-445

Read Abstract (New Window)

Masi G. (2004)

Pharmacotherapy of pervasive developmental disorders in children and adolescents.

CNS Drugs

18(14), pp. 1031-1052

Read Abstract (New Window)

Ming X. et al. (2008)

Use of clonidine in children with autism spectrum disorders.

Brain and Development

30(7), pp. 454-460

Read Abstract (New Window)

Parikh M. , Kolevzon A. , Hollander E. (2008)

Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability

Journal of Child and Adolescent Psychopharmacology

April, 18(2), pp. 157-178

Read Abstract (New Window)

American Society of Health-System Pharmacists (2010)

Clonidine.

Bethesda, MD: U.S. National Library of Medicine

Read Full (New Window)

American Society of Health-System Pharmacists (2010)

Propranolol Oral.

Bethesda, MD: U.S. National Library of Medicine

Read Full (New Window)

Posey D. J. , McDougle C. J. (2001)

Pharmacotherapeutic management of autism.

Expert Opinion on Pharmacotherapy

2(4), pp. 587-600

Read Abstract (New Window)

Reichow B. , Volkmar F. R. , Bloch M. H. (2013)

Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders.

Journal of Autism and Developmental Disorders

43(10), pp. 2435-2441.

Read Abstract (New Window) Read Full (New Window)

Riddle M. A. et al. (1999)

Anxiolytics, adrenergic agents, and naltrexone.

Journal of the American Academy of Child and Adolescent Psychiatry

38(5), pp. 546-556

Read Abstract (New Window)

Scahill L. et al. (2006)

A prospective open trial of guanfacine in children with pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

16(5), pp. 589-598.

Read Abstract (New Window) Read Full (New Window)

Stigler K. A. , McDougle C. J. (2008)

Pharmacotherapy of irritability in pervasive developmental disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 739-752

Read Abstract (New Window)

Taylor L. J. (2016)

Psychopharmacologic intervention for adults with autism spectrum disorder: A systematic literature review.

Research in Autism Spectrum Disorders

25 pp. 58-75.

Read Abstract (New Window)